2 unknown, 1 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Direct Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme carmustine in ethanol, conventional surgery - Brain and Central Nervous System Tumors | Phase 2 | Unknown | Direct Therapeutics | 2000-06-01 | 2013-11-06 | |
| Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm carmustine in ethanol, conventional surgery - Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 1 / Phase 2 | Unknown | Direct Therapeutics | 2000-06-01 | 2013-11-06 | |
| Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas DTI-015 - Glioma, Brain Neoplasms | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 39 | 1995-09-01 | 2018-10-31 |
Brain Neoplasms (3) · Central Nervous System Neoplasms (2) · Glioblastoma (2) · Gliosarcoma (2) · Astrocytoma (1) · Ependymoma (1) · Glioma (1) · Neoplasm Metastasis (1) · Oligodendroglioma (1)
Carmustine (2) · Ethanol (2)
United States (3)
Gene David Resnick, MD (2) · Samuel J. Hassenbusch, MD, PHD (1)